Centennial Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
7,305
+197
+3% +$5.24K 0.06% 146
2026
Q2
$171K Hold
7,108
– – 0.06% 160
2026
Q1
$200K Hold
7,108
– – 0.07% 143
2025
Q4
$177K Hold
7,108
– – 0.07% 145
2025
Q3
$181K Sell
7,108
-492
-6% -$12.1K 0.07% 141
2025
Q2
$184K Sell
7,600
-1,500
-16% -$35K 0.08% 143
2025
Q1
$231K Hold
9,100
– – 0.11% 127
2024
Q4
$241K Sell
9,100
-800
-8% -$21.7K 0.11% 124
2024
Q3
$287K Sell
9,900
-270
-3% -$7.88K 0.13% 113
2024
Q2
$285K Buy
10,170
+175
+2% +$4.82K 0.14% 104
2024
Q1
$277K Hold
9,995
– – 0.14% 113
2023
Q4
$288K Sell
9,995
-917
-8% -$27.7K 0.17% 98
2023
Q3
$362K Buy
10,912
+367
+3% +$13K 0.25% 90
2023
Q2
$387K Hold
10,545
– – 0.26% 88
2023
Q1
$430K Sell
10,545
-1,150
-10% -$49.7K 0.28% 90
2022
Q4
$599K Buy
+11,695
New +$561K 0.34% 78

Other funds holding PFE

Centennial Bank's PFE Position: Q3 2026 in Review

Centennial Bank increased its Pfizer (PFE) stake by 2.8% in Q3 2026, buying an estimated $5.24K and bringing the position to 7,305 shares worth $208K. The position accounts for 0.06% of the portfolio, ranked #146.

Centennial Bank first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $599K in Q4 2022. 1,860 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Centennial Bank held 7,305 shares of Pfizer worth $208K as of Q3 2026.
  • Centennial Bank bought 197 Pfizer shares in Q3 2026, an estimated $5.24K.
  • Pfizer made up 0.06% of Centennial Bank's portfolio in Q3 2026, its #146 holding.
  • Centennial Bank first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
  • Centennial Bank's Pfizer position peaked at $599K in Q4 2022.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Centennial Bank's 13F filing for Q3 2026, filed 9 Nov 2026.